Chengwu Jumei Pharmaceutical Technology Co., Ltd. has a unified social credit code/registration number of 91371723312667859y, and the enterprise is in the opening state.
The business scope of Chengwu Jumei Pharmaceutical Technology Co., Ltd. is: the production and sales of pharmaceutical intermediates cimetidine dimer, 4- methylimidazole, acetone aldehyde, sodium theophylline, ranitidine base and chlorpheniramine; Research and development and technology transfer of pharmaceutical intermediates; Housing rental service. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Shandong province, the total registered capital of companies with similar business scope is 684 million yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million yuan, totaling 10. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
See more information and materials of Chengwu Julmei Pharmaceutical Technology Co., Ltd. through Baidu Enterprise Credit.